Skip to main content

Breadcrumb

  1. Home

Percutaneous HydroDiscectomy Compared to TESI for Radiculopathy

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Percutaneous HydroDiscectomy Compared to TESI for Radiculopathy

Risk Stratification After Acute Myocardial Infarction With Cardiac MRI

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Risk Stratification After Acute Myocardial Infarction With Cardiac MRI

The Human Epilepsy Project

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about The Human Epilepsy Project

Tolerization Reduces Intolerance to Pegloticase and Prolongs the Urate Lowering Effect

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Tolerization Reduces Intolerance to Pegloticase and Prolongs the Urate Lowering Effect

Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Safety and Efficacy Phase 3 Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children

Safety, Clinical Activity, Pharmacokinetics (PK) and Pharmacodynamics Study of GSK2879552, Alone or With Azacitidine, in Subjects With High Risk Myelodysplastic Syndromes (MDS)

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Safety, Clinical Activity, Pharmacokinetics (PK) and Pharmacodynamics Study of GSK2879552, Alone or With Azacitidine, in Subjects With High Risk Myelodysplastic Syndromes (MDS)

Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Participants With Hormone Receptor-positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Advanced or Metastatic Breast Cancer

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Dose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Participants With Hormone Receptor-positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Advanced or Metastatic Breast Cancer

Efficacy and Safety of Ularitide for the Treatment of Acute Decompensated Heart Failure

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Efficacy and Safety of Ularitide for the Treatment of Acute Decompensated Heart Failure

HCV Group Evaluation and Treatment Uptake (HCV GET-UP) Intervention

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about HCV Group Evaluation and Treatment Uptake (HCV GET-UP) Intervention

Conscious Sedation vs General Anesthesia in TAVR Patients

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Conscious Sedation vs General Anesthesia in TAVR Patients

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 122
  • Page 123
  • Page 124
  • Page 125
  • Page 126
  • Page 127
  • Page 128
  • Page 129
  • Page 130
  • …
  • Next page Next
  • Last page Last
Subscribe to